0001752724-24-020875.txt : 20240208 0001752724-24-020875.hdr.sgml : 20240208 20240208124117 ACCESSION NUMBER: 0001752724-24-020875 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 EFFECTIVENESS DATE: 20240208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MFS SERIES TRUST II CENTRAL INDEX KEY: 0000798250 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-04775 FILM NUMBER: 24607949 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 18006372929 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: MFS SERIES TRUST II /MA/ DATE OF NAME CHANGE: 19940131 FORMER COMPANY: FORMER CONFORMED NAME: MFS LIFETIME EMERGING GROWTH FUND DATE OF NAME CHANGE: 19930408 FORMER COMPANY: FORMER CONFORMED NAME: LIFETIME EMERGING GROWTH TRUST DATE OF NAME CHANGE: 19920703 0000798250 S000002419 MFS Growth Fund C000006430 A MFEGX C000006431 R4 MFEJX C000006435 B MEGBX C000006436 C MFECX C000006437 I MFEIX C000006439 R1 MFELX C000006441 R2 MEGRX C000006442 R3 MFEHX C000102727 R6 MFEKX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000798250 XXXXXXXX 811-04775 true false false N-1A true MFS Series Trust II 811-04775 0000798250 549300W3GYF777J7J466 111 Huntington Avenue Boston 02199 US-MA US 617-954-5000 The Depository Trust Company 55 Water Street New York 10041 12128551000 Central Clearinghouse Massachusetts Financial Services Company 111 Huntington Avenue Boston 02199 16179545000 Investment adviser TerraNua U.S. Corp d.b.a. My Compliance Office 535 5th Avenue, 4th floor New York 10017 18669512280 Personal Trading System MFS Fund Distributors, Inc. 111 Huntington Avenue Boston 02199 16179545000 Principal underwriter Institutional Shareholder Services, Inc. 702 King Farm Boulevard Suite 400 Rockville 20850-4045 13015560500 Proxy voting administrator Icertis 14711 NE 29th Place, Suite 100 Bellevue 98007 14258697649 Contract management system SS&C Technologies 333 West 11th Street Kansas City 64105 18164351000 Technology Vendor Iron Mountain, Inc. 1 Federal Street Boston 02110 18008994766 Storage Vendor MFS Service Center, Inc. 111 Huntington Avenue Boston 02199 16179545000 Transfer agent Ropes & Gray Prudential Tower 800 Boylston Street Boston 02199-3600 16179517000 Counsel Charles River Development 700 District Avenue Burlington 01803 17812380099 Investment related records JPMorgan Chase Bank N.A. 383 Madison Avenue New York 10179 12122706000 Custodian Micro Focus, LLC 4555 Great America Parkway Suite 400 Santa Clara 95054-1243 16502586827 Storage Vendor N N N-1A 1 Y Steven E. Buller N/A N Maryanne L. Roepke N/A N John A. Caroselli N/A N James W. Kilman, Jr. N/A N Clarence Otis, Jr. N/A N Michael W. Roberge N/A Y John P. Kavanaugh N/A N Maureen R. Goldfarb N/A N Peter D. Jones N/A N Laurie J. Thomsen N/A N Rosa E. Licea-Mailloux N/A 111 Huntington Avenue Boston 02199 XXXXXX N N N N N N N MFS FUND DISTRIBUTORS, INC. 8-45321 000031052 N/A Y N DELOITTE & TOUCHE LLP 34 N/A N N N N N N MFS Growth Fund S000002419 K4ZYIH3WSXKUSPKIPM59 N 9 0 0 N/A N N Y N N JPMorgan Chase Bank N.A. 8I5DZWZKVSZI1NUHU748 N N Revenue sharing split Cash collateral reinvestment fee 1717922.45000000 3495.63000000 Rule 12d1-4 (17 CFR 270.12d1-4) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 18f-4 (17 CFR 270.18f-4) Rule 32a-4 (17 CFR 270.32a-4) Rule 22d-1 (17 CFR 270.22d-1) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Rule 18f-4(f)(17 CFR 270.18f-4(f)) Rule 17a-7 (17 CFR 270.17a-7) Y Y N N MASSACHUSETTS FINANCIAL SERVICES COMPANY 801-17352 000110045 1G3OSH3GLGJ7X1JC5I61 N MFS SERVICE CENTER, INC. 84-1316 N/A Y N N IHS Markit 549300HLPTRASHS0E726 GB N Refinitiv U.S. Holdings Inc. 549300WQWDPFSMQ8I087 N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N N JPMorgan Chase Bank, National Association 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) J.P. Morgan SE 549300ZK53CNGEEI6A29 FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N MFS Service Center, Inc. 084-01316 SEC identifier Y N N MASSACHUSETTS FINANCIAL SERVICES 1G3OSH3GLGJ7X1JC5I61 Y N N Merrill Lynch, Pierce, Fenner & Smith Inc. 8-07221 000007691 8NAV47T0Y26Q87Y0QP81 88343.96000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 69728.71000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 316396.53000000 Jefferies LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 178082.07000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 86325.89000000 Goldman Sachs & Co. LLC 8-00129 000000361 FOR8UP27PHTHYVLBNG30 174013.39000000 BTIG, LLC 8-65473 000122225 549300GTG9PL6WO3EC51 208169.86000000 BMO Capital Markets Corp. 8-34344 000016686 RUC0QBLBRPRCU4W1NE59 184745.17000000 UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 69460.15000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 139380.37000000 1849976.47000000 Citigroup Global Markets Inc. 8-08177 000007059 MBNUM2BPBDO7JBLYG310 772619.40000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 92223340.71999999 State Street Global Markets, LLC 8-69862 000285852 549300FDEDF5ORXCMQ56 67956538.96999999 Healthcare of Ontario Pension Plan Trust Fund N/A N/A KRVONIXV1JBEY6WQ6092 CA 9052827.12000000 Bank of New York Mellon Corp. N/A N/A WFLLPEPC7FZXENRZV188 158189.40000000 170163515.61000001 Y 36553485972.00000000 Uncommitted 100000000.00000000 N Uncommitted 200000000.00000000 N Committed 1450000000.00000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 NCEN_MFS_Series_Trust_II.txt REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Trustees of MFS Series Trust II and the Shareholders of MFS Growth Fund: In planning and performing our audit of the financial statements of MFS Growth Fund (the "Fund") (one of the series of MFS Series Trust II) as of and for the year ended November 30, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management of the fund and trustees of the trust; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a fund's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a fund's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund's internal control over financial reporting and its operations, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of November 30, 2023. This report is intended solely for the information and use of management, the Board of Trustees of MFS Series Trust II and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/Deloitte & Touche LLP Boston, Massachusetts January 12, 2024